Requirements or Incentives by Government for the Use of Long-Acting Contraceptives: Board of Trustees, American Medical Association

doi:10.1001/jama.1992.03480130134039

You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Welcome | My Account | E-mail Alerts | Access Rights | Sign In

Vol. 267 No. 13, April 1, 1992

JAMA
	•	Online Features

Board of Trustees Report

This Article
•	Abstract
•	Full text PDF
•	Correction
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Citing articles on HighWire
•	Citing articles on Web of Science (3)
•	Contact me when this article is cited

Related Content
•	Similar articles in JAMA

Social Bookmarking
	What's this?

Requirements or Incentives by Government for the Use of Long-Acting Contraceptives

Board of Trustees, American Medical Association

Scott L. Bernstein; Lonnie R. Bristow, MD (Executive Committee); John L. Clowe, MD (President-Elect); Mary Ann Contogiannis, MD (Resident Trustee); Greenville, NC; Richard F. Corlin, MD (Vice Speaker); Nancy W. Dickey, MD (Executive Committee); Palma E. Formica, MD; New Brunswick, NJ; William E. Jacott, MD; Daniel H. Johnson, Jr, MD (Speaker); Robert E. McAfee, MD (Vice Chair); Joseph T. Painter, MD (Chair); Thomas R. Reardon, MD; John J. Ring, MD (President); Raymond Scalettar, MD (Secretary-Treasurer); Jerald R. Schenken, MD; John P. Seward, MD; C. John Tupper, MD (Immediate Past President); Frank B. Walker, MD; Percy Wootton, MD; Dick K. Cason, MD; Frederick W. Cheney, MD; Clarence H. Denser, Jr, MD; Raymond C. Grandon, MD (Chair); Francis X. Lieb, MD; John A. Martin, MD; Eugene S. Ogrod II, MD; David Orentlicher, MD, JD (Secretary); Anita K. Schweickart; David Orentlicher, MD, JD.

JAMA. 1992;267(13):1818-1821.

References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Shoupe D, Mishell DR. Norplant: subdermal implant system for long-term contraception. Am J Obstet Gynecol. 1989;160:1286-1292.
2. Segal S. A new delivery system for contraceptive steroids. Am J Obstet Gynecol. 1987;157:1090-1092.
3. Slater & Baker v Stapleton, 95 Eng Rep 860 (KB 1767).
4. Canterbury v Spence, 464 F2d 772, 780 (DC Cir), cert denied, 409 US 1064(1972) Schloendorffv Society of New York Hospital, 211 NY 125, 105 NE 92, 93 [1914] [Cardozo, J.]
5. Cruzan v Director, Missouri Department of Health, 110 SCt 2841 (1990).
6. Orentlicher D. The right to die after Cruzan. JAMA. 1990;264:2444-2446.
7. Winston v Lee, 470 US 753 (1985).
8. Skinnerv Railway Labor Executives'Assn, 109 SCt 1402, 1412-1413 (1989).
9. Schmerber v California, 384 US 757, 772(1966).
10. RochinvCalifornia,342US165, 165,173-174(1952).
11. American Medical Association. Drug Evaluations. Chicago, Ill: American Medical Association; 1990;8:20.
12. Zairev Dalsheim, 698 F Supp 57 (SDNY1988).
13. Washington v Harper, 110 SCt 1028 (1990).
14. Pena v New York State Div for Youth, 419 F Supp 203 (SDNY 1976).
15. Nelson v Heyne, 355 F Supp 451 (ND Ind 1972).
16. Skinner v Oklahoma, 316 US 527 (1942).
17. Whalen v Roe, 429 US 589, 599-600 (1977).
18. Griswold v Connecticut, 381 US 479 (1965).
19. Webster v Reproductive Health Services, 109 SCt 3040 (1989).
20. Rust v Sullivan, 111 SCt 1759 (1991).
21. O'Toole R, Turbett P, Nalepka C. Theories, professional knowledge, and diagnosis of child abuse. In: Finkelhor D, Gelles RJ, Hotaling GT, Straus MA, eds. The Dark Side of Families: Current Family Violence Research. Beverly Hills, Calif: Sage Publications; 1983.
22. Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med. 1990;322:1202-1206.
23. Hayman RL. Presumptions ofjustice: law, politics, and the mentally retarded parent. Harvard Law Rev. 1990;103:1201-1271.
24. Dickens B. No contraceptive sterilization of the mentally retarded: the dawn of 'Eve.' Can Med Assoc J. 1987;137:65-67.
25. Berlin FS, Meinecke CF. Treatment of sex offenders with antiandrogenic medication: conceptualization review of treatment modalities, and preliminary findings. Am J Psychol. 1981;138:601-607.
26. Kiersch TA. Treatment of sex offenders with depo-provera. Bull Am Acad Psychiatry Law. 1990;18:179-187.
27. Furby L, Weinrott MR, Blackshaw L. Sex offender recidivism: a review. Psychol Bull. 1989;105:3-30.
28. Melella JT, Travin S, Cullen K. Legal and ethical issues in the use of antiandrogens in treating sex offenders. Bull Am Acad Psychiatry Law. 1989;17:223-232.
29. People v Gauntlett, 352 NW2d 310 (Mich App 1984).
30. LaFave WR, Israel JH. Criminal Procedure. St. Paul, Minn: West Publishing Co; 1984;3:144.
31. People v Keller, 143 Cal Rptr 184, 76 Cal App 3d 827, 832 n2 (Cal Ct App 1978).
32. In re Bushman, 463 P2d 727 (Cal 1970).
33. People v Pointer, 151 Cal App 3d 1128 (1984).
34. State of Kansas v Mosburg, 768 P2d 313 (Kan App 1989).
35. Howland v State, 420 So2d 918 (Fla Dist Ct App 1982).
36. Sullivan KM. Unconstitutional conditions. Harvard Law Rev. 1989;102:1413-1506.
37. Harperv Virginia State Board of Elections, 86 SCt 1079, 1081 (1966).

Add to CiteULike CiteULike Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

| | |